# Novanta Inc: filings

NOVT · Nasdaq · CIK 1076930 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/novt.md) · [Financials](/companies/novt/financials.md) · [Filings](/companies/novt/filings.md) · [Insiders](/companies/novt/insiders.md)

## Reports and events: 386 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 530, 8-K 221, SC 13D/A 63, 10-Q 54, 3 42, SC 13G/A 37, 144 30, 10-K 18, DEF 14A 17, SC 13G 16, SD 13, 4/A 11, ARS 9, 5 7, SC 13D 7, 8-K/A 6, NT 10-Q 6, PRE 14A 4, S-3ASR 4, S-8 4, SCHEDULE 13G/A 4, CORRESP 3, SCHEDULE 13G 3, UPLOAD 3, 424B5 2, 8-A12B 2, DEFA14A 2, EFFECT 2, NT 10-K 2, S-3 2, 144/A 1, 25-NSE 1, 3/A 1, 424B7 1, CERT 1, CERTNAS 1, CT ORDER 1, DEFR14A 1, FWP 1, POSASR 1, PREC14A 1, S-3/A 1, T-3 1, T-3/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-02 | 20:30 ET | [8-K/A](/filings/0001193125-26-412444.md) | 9.01 Financial statements and exhibits | 0001193125-26-412444 |
| 2026-08-05 | 21:00 ET | [10-Q](/filings/0001193125-26-335404.md) | Quarterly report, period 2026-07-03 | 0001193125-26-335404 |
| 2026-08-05 | 20:50 ET | [8-K](/filings/0001193125-26-335356.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-335356 |
| 2026-07-27 | 12:15 ET | [8-K](/filings/0001193125-26-316947.md) | 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-316947 |
| 2026-06-09 | 21:00 ET | [8-K](/filings/0001193125-26-263979.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-263979 |
| 2026-06-09 | 10:02 ET | [8-K](/filings/0001193125-26-262867.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-262867 |
| 2026-05-29 | 20:45 ET | [8-K](/filings/0001193125-26-248524.md) | 5.07 Shareholder vote results | 0001193125-26-248524 |
| 2026-05-15 | 20:45 ET | [8-K](/filings/0001193125-26-227053.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-227053 |
| 2026-05-11 | 21:00 ET | [10-Q](/filings/0001193125-26-217064.md) | Quarterly report, period 2026-04-03 | 0001193125-26-217064 |
| 2026-05-11 | 20:45 ET | [8-K](/filings/0001193125-26-216984.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-216984 |
| 2026-04-24 | 13:00 ET | [DEF 14A](/filings/0001193125-26-175367.md) | Proxy statement, period 2026-05-28 | 0001193125-26-175367 |
| 2026-02-23 | 21:57 ET | [10-K](/filings/0001193125-26-064230.md) | Annual report, period 2025-12-31 | 0001193125-26-064230 |
| 2026-02-23 | 21:45 ET | [8-K](/filings/0001193125-26-064191.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-064191 |
| 2025-12-01 | 21:30 ET | [8-K](/filings/0001193125-25-303940.md) | 7.01 Regulation FD disclosure | 0001193125-25-303940 |
| 2025-11-13 | 21:46 ET | [8-K](/filings/0001193125-25-280353.md) | 7.01 Regulation FD disclosure | 0001193125-25-280353 |
| 2025-11-12 | 22:10 ET | [8-K](/filings/0001193125-25-277939.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-277939 |
| 2025-11-03 | 22:11 ET | [10-Q](/filings/0001193125-25-262774.md) | Quarterly report, period 2025-09-26 | 0001193125-25-262774 |
| 2025-11-03 | 22:00 ET | [8-K](/filings/0001193125-25-262744.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-262744 |
| 2025-09-18 | 20:30 ET | [8-K](/filings/0001193125-25-207465.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-207465 |
| 2025-09-18 | 12:00 ET | [8-K](/filings/0001193125-25-206858.md) | 8.01 Other events | 0001193125-25-206858 |
| 2025-08-05 | 13:31 ET | [10-Q](/filings/0000950170-25-102475.md) | Quarterly report, period 2025-06-27 | 0000950170-25-102475 |
| 2025-08-05 | 12:00 ET | [8-K](/filings/0000950170-25-102416.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-102416 |
| 2025-07-11 | 20:30 ET | [8-K](/filings/0000950170-25-095309.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-095309 |
| 2025-07-02 | 20:30 ET | [8-K](/filings/0000950170-25-093046.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950170-25-093046 |
| 2025-06-09 | 20:30 ET | [8-K](/filings/0000950170-25-083785.md) | 2.05 Exit or disposal costs | 0000950170-25-083785 |
| 2025-06-02 | 20:00 ET | [8-K](/filings/0000950170-25-080208.md) | 5.07 Shareholder vote results | 0000950170-25-080208 |
| 2025-05-06 | 13:30 ET | [10-Q](/filings/0000950170-25-064018.md) | Quarterly report, period 2025-03-28 | 0000950170-25-064018 |
| 2025-05-06 | 12:00 ET | [8-K](/filings/0000950170-25-063976.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-063976 |
| 2025-04-25 | 13:00 ET | [DEF 14A](/filings/0000950170-25-058366.md) | Proxy statement, period 2025-05-29 | 0000950170-25-058366 |
| 2025-02-25 | 22:16 ET | [8-K](/filings/0000950170-25-026854.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-026854 |
| 2025-02-25 | 14:30 ET | [10-K](/filings/0000950170-25-026131.md) | Annual report, period 2024-12-31 | 0000950170-25-026131 |
| 2025-02-25 | 13:00 ET | [8-K](/filings/0000950170-25-026093.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-026093 |
| 2024-11-05 | 14:30 ET | [10-Q](/filings/0000950170-24-121113.md) | Quarterly report, period 2024-09-27 | 0000950170-24-121113 |
| 2024-11-05 | 13:00 ET | [8-K](/filings/0000950170-24-121078.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-121078 |
| 2024-08-23 | 20:18 ET | [8-K](/filings/0000950170-24-100196.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-100196 |
| 2024-08-06 | 13:30 ET | [10-Q](/filings/0000950170-24-091261.md) | Quarterly report, period 2024-06-28 | 0000950170-24-091261 |
| 2024-08-06 | 12:00 ET | [8-K](/filings/0000950170-24-091213.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-091213 |
| 2024-08-02 | 20:05 ET | [8-K](/filings/0000950170-24-089941.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-089941 |
| 2024-07-12 | 20:05 ET | [8-K](/filings/0000950170-24-083196.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-083196 |
| 2024-05-09 | 20:00 ET | [8-K](/filings/0000950170-24-056836.md) | 5.07 Shareholder vote results | 0000950170-24-056836 |
| 2024-05-07 | 13:31 ET | [10-Q](/filings/0000950170-24-054007.md) | Quarterly report, period 2024-03-29 | 0000950170-24-054007 |
| 2024-05-07 | 12:00 ET | [8-K](/filings/0000950170-24-053957.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-053957 |
| 2024-04-03 | 13:00 ET | [DEF 14A](/filings/0000950170-24-040709.md) | Proxy statement, period 2024-05-08 | 0000950170-24-040709 |
| 2024-03-15 | 20:30 ET | [8-K](/filings/0000950170-24-032232.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0000950170-24-032232 |
| 2024-02-28 | 14:30 ET | [10-K](/filings/0000950170-24-021689.md) | Annual report, period 2023-12-31 | 0000950170-24-021689 |
| 2024-02-28 | 13:00 ET | [8-K](/filings/0000950170-24-021670.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-021670 |
| 2024-01-02 | 21:30 ET | [8-K](/filings/0000950170-24-000289.md) | 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-000289 |
| 2023-11-14 | 21:16 ET | [8-K](/filings/0000950170-23-063728.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-063728 |
| 2023-11-07 | 14:30 ET | [10-Q](/filings/0000950170-23-059817.md) | Quarterly report, period 2023-09-29 | 0000950170-23-059817 |
| 2023-11-07 | 13:00 ET | [8-K](/filings/0000950170-23-059776.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-059776 |

Page 1 of 8. [Older](/companies/novt/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:03 ET. No prices; not investment advice.